1 Study Coverage
1.1 Immunomodulators Product Introduction
1.2 Market Segments
1.3 Key Immunomodulators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunomodulators Market Size Growth Rate by Type
1.4.2 Immunosuppressant
1.4.3 Immunostimulants
1.5 Market by Application
1.5.1 Global Immunomodulators Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Respiratory
1.5.4 HIV
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunomodulators Market Size, Estimates and Forecasts
2.1.1 Global Immunomodulators Revenue 2015-2026
2.1.2 Global Immunomodulators Sales 2015-2026
2.2 Global Immunomodulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunomodulators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunomodulators Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunomodulators Competitor Landscape by Players
3.1 Immunomodulators Sales by Manufacturers
3.1.1 Immunomodulators Sales by Manufacturers (2015-2020)
3.1.2 Immunomodulators Sales Market Share by Manufacturers (2015-2020)
3.2 Immunomodulators Revenue by Manufacturers
3.2.1 Immunomodulators Revenue by Manufacturers (2015-2020)
3.2.2 Immunomodulators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunomodulators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunomodulators Revenue in 2019
3.2.5 Global Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunomodulators Price by Manufacturers
3.4 Immunomodulators Manufacturing Base Distribution, Product Types
3.4.1 Immunomodulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunomodulators Product Type
3.4.3 Date of International Manufacturers Enter into Immunomodulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunomodulators Market Size by Type (2015-2020)
4.1.1 Global Immunomodulators Sales by Type (2015-2020)
4.1.2 Global Immunomodulators Revenue by Type (2015-2020)
4.1.3 Immunomodulators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunomodulators Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunomodulators Sales Forecast by Type (2021-2026)
4.2.2 Global Immunomodulators Revenue Forecast by Type (2021-2026)
4.2.3 Immunomodulators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunomodulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunomodulators Market Size by Application (2015-2020)
5.1.1 Global Immunomodulators Sales by Application (2015-2020)
5.1.2 Global Immunomodulators Revenue by Application (2015-2020)
5.1.3 Immunomodulators Price by Application (2015-2020)
5.2 Immunomodulators Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunomodulators Sales Forecast by Application (2021-2026)
5.2.2 Global Immunomodulators Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunomodulators Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immunomodulators by Country
6.1.1 North America Immunomodulators Sales by Country
6.1.2 North America Immunomodulators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunomodulators Market Facts & Figures by Type
6.3 North America Immunomodulators Market Facts & Figures by Application
7 Europe
7.1 Europe Immunomodulators by Country
7.1.1 Europe Immunomodulators Sales by Country
7.1.2 Europe Immunomodulators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunomodulators Market Facts & Figures by Type
7.3 Europe Immunomodulators Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immunomodulators by Region
8.1.1 Asia Pacific Immunomodulators Sales by Region
8.1.2 Asia Pacific Immunomodulators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunomodulators Market Facts & Figures by Type
8.3 Asia Pacific Immunomodulators Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immunomodulators by Country
9.1.1 Latin America Immunomodulators Sales by Country
9.1.2 Latin America Immunomodulators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunomodulators Market Facts & Figures by Type
9.3 Central & South America Immunomodulators Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immunomodulators by Country
10.1.1 Middle East and Africa Immunomodulators Sales by Country
10.1.2 Middle East and Africa Immunomodulators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunomodulators Market Facts & Figures by Type
10.3 Middle East and Africa Immunomodulators Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Immunomodulators Products Offered
11.1.5 Roche Related Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Description and Business Overview
11.2.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc. Immunomodulators Products Offered
11.2.5 Amgen Inc. Related Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Description and Business Overview
11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Immunomodulators Products Offered
11.3.5 Abbott Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Immunomodulators Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Description and Business Overview
11.5.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG Immunomodulators Products Offered
11.5.5 Novartis AG Related Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Description and Business Overview
11.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly and Company Immunomodulators Products Offered
11.6.5 Eli Lilly and Company Related Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Corporation Information
11.7.2 Bristol-Myers Squibb Company Description and Business Overview
11.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Company Immunomodulators Products Offered
11.7.5 Bristol-Myers Squibb Company Related Developments
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Corporation Information
11.8.2 Merck & Co. Inc. Description and Business Overview
11.8.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Inc. Immunomodulators Products Offered
11.8.5 Merck & Co. Inc. Related Developments
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description and Business Overview
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Immunomodulators Products Offered
11.9.5 Biogen Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Immunomodulators Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunomodulators Market Estimates and Projections by Region
12.1.1 Global Immunomodulators Sales Forecast by Regions 2021-2026
12.1.2 Global Immunomodulators Revenue Forecast by Regions 2021-2026
12.2 North America Immunomodulators Market Size Forecast (2021-2026)
12.2.1 North America: Immunomodulators Sales Forecast (2021-2026)
12.2.2 North America: Immunomodulators Revenue Forecast (2021-2026)
12.2.3 North America: Immunomodulators Market Size Forecast by Country (2021-2026)
12.3 Europe Immunomodulators Market Size Forecast (2021-2026)
12.3.1 Europe: Immunomodulators Sales Forecast (2021-2026)
12.3.2 Europe: Immunomodulators Revenue Forecast (2021-2026)
12.3.3 Europe: Immunomodulators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunomodulators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunomodulators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunomodulators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunomodulators Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunomodulators Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunomodulators Sales Forecast (2021-2026)
12.5.2 Latin America: Immunomodulators Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunomodulators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunomodulators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunomodulators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunomodulators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunomodulators Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunomodulators Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunomodulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Roche、Amgen Inc.、Abbott、Johnson & Johnson、Novartis AG、Eli Lilly and Company、Bristol-Myers Squibb Company、Merck & Co. Inc.、Biogen
【免責事項】
https://www.globalresearch.jp/disclaimer